Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Mucocutaneous Lymph Node Syndrome

• Rivaroxaban Versus Warfarin for Thromboprophylaxis in Children With Giant Coronary Aneurysms After Kawasaki Disease
• Defibrotide in Children With High Risk Kawasaki Disease
• Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
• A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
• Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease
• Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
• Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
• Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
• A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)
• KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
• Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
• Different Doses of IVIG for Kawasaki Disease
• Anakinra and Kawasaki Disease
• Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease
• Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
• Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
• Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease
• Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
• Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
• Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
• Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities
• Etanercept in Kawasaki Disease
• Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
• Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease
• Infliximab (Remicade) for Patients With Acute Kawasaki Disease
• A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
• Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
• Prevention of Coronary Aneurysms in Kawasaki Syndrome